- Home
- GATX vs LNTH Comparison
GATX vs LNTH Comparison
Compare GATX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GATX
- LNTH
- Stock Information
- Founded
- GATX 1898
- LNTH 1956
- Country
- GATX United States
- LNTH United States
- Employees
- GATX N/A
- LNTH N/A
- Industry
- GATX Transportation Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GATX Consumer Discretionary
- LNTH Health Care
- Exchange
- GATX Nasdaq
- LNTH Nasdaq
- Market Cap
- GATX 5.5B
- LNTH 5.7B
- IPO Year
- GATX N/A
- LNTH 2015
- Fundamental
- Price
- GATX $149.10
- LNTH $70.57
- Analyst Decision
- GATX Buy
- LNTH Strong Buy
- Analyst Count
- GATX 2
- LNTH 5
- Target Price
- GATX $172.50
- LNTH $131.20
- AVG Volume (30 Days)
- GATX 180.0K
- LNTH 1.1M
- Earning Date
- GATX 07-29-2025
- LNTH 08-06-2025
- Dividend Yield
- GATX 1.64%
- LNTH N/A
- EPS Growth
- GATX 34.45
- LNTH N/A
- EPS
- GATX 8.74
- LNTH 3.53
- Revenue
- GATX $1,671,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- GATX $10.94
- LNTH $4.57
- Revenue Next Year
- GATX $5.40
- LNTH $9.41
- P/E Ratio
- GATX $17.08
- LNTH $19.99
- Revenue Growth
- GATX 11.74
- LNTH 12.53
- 52 Week Low
- GATX $127.70
- LNTH $69.12
- 52 Week High
- GATX $168.89
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- GATX 37.74
- LNTH 35.55
- Support Level
- GATX $151.86
- LNTH $70.40
- Resistance Level
- GATX $160.74
- LNTH $73.52
- Average True Range (ATR)
- GATX 3.08
- LNTH 2.48
- MACD
- GATX -0.57
- LNTH -0.27
- Stochastic Oscillator
- GATX 0.43
- LNTH 10.21
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.